The Urgency of Addressing the Supply Chain Issue in Pharmaceuticals

💊China manufactures 60-70% of generic drugs in the US, making it a dominant source of active pharmaceutical ingredients.

🌍Over 80% of APIs for essential medicines in the US have no domestic manufacturing source.

📉Chinese API prices have more than doubled since 2020, leading to increased costs of medications.

🌐Exploring partnerships with countries like Poland and Ireland can help diversify pharmaceutical production.

🏭Onshoring pharmaceutical production is crucial to reduce reliance on China and ensure a stable supply chain.

Why is China's dominance in pharmaceutical production concerning?

—China's dominance in pharmaceutical production is concerning because it leads to an overreliance on a single country for essential medications. This reliance poses risks in terms of supply chain disruptions, increased prices, and lack of predictability in medication availability.

How have Chinese API prices impacted medication costs?

—Chinese API prices have more than doubled since 2020. This increase in prices directly affects the cost of medications, making them more expensive for consumers and healthcare systems.

What percentage of essential medicines in the US have no domestic manufacturing source?

—Over 80% of APIs for essential medicines in the US have no domestic manufacturing source. This means the US heavily depends on imports for these crucial medications.

Which countries could be potential partners for diversifying pharmaceutical production?

—Countries like Poland and Ireland are potential partners for diversifying pharmaceutical production. These countries have shown a likeminded approach and have the capability to produce pharmaceuticals.

Why is onshoring pharmaceutical production important?

—Onshoring pharmaceutical production is important to reduce reliance on countries like China and ensure a stable supply chain. It allows for better control over the production process and safeguards against supply chain disruptions.

00:00Addressing the supply chain issue in pharmaceuticals is a priority.

00:22Relying overwhelmingly on communist China for pharmaceuticals is dangerous.

00:30252 drugs are currently in shortage in the United States with no pattern or predictability.

00:49China manufactures 60-70% of generic drugs in the United States.

01:09Over 80% of APIs for essential medicines in the US have no domestic manufacturing source.

01:32Chinese API prices have more than doubled since 2020.

02:23Exploring partnerships with countries like Poland and Ireland can help diversify pharmaceutical production.

03:13Onshoring pharmaceutical production is crucial to reduce reliance on China and ensure a stable supply chain.